0002070295-25-000002.txt : 20250819 0002070295-25-000002.hdr.sgml : 20250819 20250819120009 ACCESSION NUMBER: 0002070295-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250819 DATE AS OF CHANGE: 20250819 EFFECTIVENESS DATE: 20250819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cirrus Therapeutics, Inc. CENTRAL INDEX KEY: 0002078601 ORGANIZATION NAME: EIN: 882275758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-555163 FILM NUMBER: 251230264 BUSINESS ADDRESS: STREET 1: CIRRUS THERAPEUTICS STREET 2: 750 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-959-3124 MAIL ADDRESS: STREET 1: CIRRUS THERAPEUTICS STREET 2: 750 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0002078601 Cirrus Therapeutics, Inc. 750 Main Street Cambridge MA MASSACHUSETTS 02139 (617) 959-3124 DELAWARE None None Corporation true 2022 Ying Kai Chan c/o Cirrus Therapeutics, Inc. 750 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Promoter Andrew Dick c/o Cirrus Therapeutics, Inc. 750 Main Street Cambridge MA MASSACHUSETTS 02139 Director Promoter Alexandra Cantley c/o Cirrus Therapeutics, Inc. 750 Main Street Cambridge MA MASSACHUSETTS 02139 Director Khoo Shih c/o Cirrus Therapeutics, Inc. 750 Main Street Cambridge MA MASSACHUSETTS 02139 Director Other Technology Not Applicable 06b false 2025-08-04 false true false 0 15698319 6698321 8999998 false 8 0 0 0 false Cirrus Therapeutics, Inc. /s/ Ying Kai Chan Ying Kai Chan President 2025-08-19